The growing desire for personalized treatments coupled with an aging population across numerous countries and rising chronic conditions are generating higher healthcare requirements, consequently leading to an elevated demand for pharmaceutical products and services.
In this context, I have highlighted three fundamentally sound pharma stocks, Pfizer Inc. (PFE), Sanofi (SNY), and GSK plc (GSK), which are trading at a discount relative to their peers and could be valuable watchlist additions.
